Mahendra Shah

Mahendra Shah

Direktor/Vorstandsmitglied bei HCMED INNOVATIONS CO., LTD.
81 Jahre
Health Technology
Finance
Consumer Services

Profil

Mahendra G.
Shah
was the founder of Semnur, Inc., founded in 2013, where the title held was Executive Chairman & Managing Director.
Dr. Shah was the founder of NextWave Pharmaceuticals, Inc., founded in 2005, where the title held was Chairman & Chief Executive Officer from 2005 to 2009.
Current jobs include Director at Scilex Pharmaceuticals, Inc., Director & Charter Member at EPPIC Global Network, Director at Cerebral Therapeutics, Inc., Director at Suzhou OMNI Pharmaceutical Co., Ltd., Director at Citrine Medicine, Inc., Director at Shanghai Rarestone Health Tech Group Co., Ltd., Director at Vivo Panda Fund LP, Director at HCmed Innovations Co Ltd since 2017, Trustee at St. John's University, and Member at The Indus Entrepreneurs.
Former jobs include Chairman, President & Chief Executive Officer at Shionogi Pharma, Inc. from 2002 to 2003; Director roles at Unimed Pharmaceuticals LLC, Introgen Therapeutics, Inc., Fortis, Inc. (United States), YM BioSciences USA, Inc., Biotie Therapies Oy, Structural Bioinformatics, Inc., Essentialis, Inc., ProtoMED, Inc., Inpharmakon Corp., Aadi Subsidiary, Inc., and Schering-Plough Research Institute and Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. Independent Director at Soleno Therapeutics, Inc. from 2018 to 2019; Independent Director at IPI Legacy Liquidation Co. from 2016 to 2023; Director at Crinetics Pharmaceuticals, Inc. from 2015 to 2018; Independent Director at Homology Medicines, Inc. from 2017 to 2019; Director at Whitehawk Therapeutics, Inc. from 2017 to 2021; Independent Non-Executive Director at Verona Pharma Ltd. from 2016 to 2025; Independent Director at Bolt Biotherapeutics, Inc. from 2016 to 2024; Senior Director-New Business Development at Fujisawa USA, Inc. from 1987 to 1990; Vice President at EJ Financial Enterprises, Inc. from 1991 to 1999.
Education includes a doctorate from St. John's University and a graduate degree from L.
M.
College of Pharmacy.

Aktive Positionen von Mahendra Shah

UnternehmenPositionBeginn
HCMED INNOVATIONS CO., LTD. Direktor/Vorstandsmitglied 15.11.2017
Private Equity Investor 01.01.2010
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Direktor/Vorstandsmitglied -
░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Mahendra Shah

UnternehmenPositionEnde
░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Mahendra Shah im Detail an

Ausbildung von Mahendra Shah

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

67

Beziehungen ersten Grades

36

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen36

Health Technology

Health Technology

Finance

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Non-Energy Minerals

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd.

Inpharmakon Corp.

Health Technology

Electronic Technology

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Mahendra Shah